In the version of this article initially published, there was an error in Figure 5D. When organizing the figure with Adobe Illustrator, we used the same picture to make sure the position is the same. However, due to our carelessness, we forgot to adjust the order of the layers, leading to the covered old one rather than the new picture, as in the published figure 5 D, the 2nd and 4th images in the upper panel were the same. We now replace the old 4th image (red arrow) in new figure 5 D. This replacement does not change the conclusion of this study. Below is the figure for erratum.
. 2022 Nov 3;18(16):6226. doi: 10.7150/ijbs.79140
MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity
Yingming Sun
1,2,#, Xiaoge Sun
1,3,#, Chengcheng You
1,4, Shijing Ma
1, Yuan Luo
1, Shan Peng
1, Fang Tang
1, Xiaoli Tian
1, Feng Wang
1, Zhengrong Huang
1,5, Hongnv Yu
6, Yu Xiao
5,7, Xiaoyong Wang
1,8, Junhong Zhang
1,8, Yan Gong
5,7,✉, Conghua Xie
1,8,✉
Yingming Sun
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
2Department of Radiation and Medical Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming, China.
Find articles by Yingming Sun
Xiaoge Sun
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
3Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Find articles by Xiaoge Sun
Chengcheng You
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
4Department of Pathology, China Three Gorges University Medical College, Yichang, China.
Find articles by Chengcheng You
Shijing Ma
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Shijing Ma
Yuan Luo
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Yuan Luo
Shan Peng
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Shan Peng
Fang Tang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Fang Tang
Xiaoli Tian
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Xiaoli Tian
Feng Wang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Feng Wang
Zhengrong Huang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
5Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Zhengrong Huang
Hongnv Yu
6Central Laboratory of Xinhua Hospital of Dalian University, Department of Medical Oncology, Xinhua Hospital of Dalian University, Dalian, China.
Find articles by Hongnv Yu
Yu Xiao
5Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
7Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Yu Xiao
Xiaoyong Wang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
8Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Xiaoyong Wang
Junhong Zhang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
8Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Junhong Zhang
Yan Gong
5Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
7Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Yan Gong
Conghua Xie
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
8Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Find articles by Conghua Xie
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
2Department of Radiation and Medical Oncology, Affiliated Sanming First Hospital of Fujian Medical University, Sanming, China.
3Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
4Department of Pathology, China Three Gorges University Medical College, Yichang, China.
5Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
6Central Laboratory of Xinhua Hospital of Dalian University, Department of Medical Oncology, Xinhua Hospital of Dalian University, Dalian, China.
7Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
8Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
✉
✉ Corresponding authors: Conghua Xie, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China, Phone: +86-27-67812607, Email: chxie_65@whu.edu.cn; and Yan Gong, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China, Phone: +86-27-67811461, Email: yan.gong@whu.edu.cn.
#These authors contributed equally to this work.
Collection date 2022.
© The author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
PMCID: PMC9682540 PMID: 36439877
This corrects the article "MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity" in volume 17 on page 2523.